These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 26902323)
1. Is Prostate-Specific Antigen Screening "Proven Ineffective Care"? Barry MJ; Albertsen PC Ann Intern Med; 2016 May; 164(10):687-8. PubMed ID: 26902323 [No Abstract] [Full Text] [Related]
2. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761 [No Abstract] [Full Text] [Related]
3. Risks of PSA screening now better understood. Peres J J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893 [No Abstract] [Full Text] [Related]
4. Lung cancer screening gets risk-specific. Peres J J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155 [No Abstract] [Full Text] [Related]
5. USPTF Prostate Cancer Screening Recommendations-A Step in the Right Direction. Carroll PR JAMA Surg; 2018 Aug; 153(8):701-702. PubMed ID: 29801146 [No Abstract] [Full Text] [Related]
6. Prostate Cancer Screening - A Perspective on the Current State of the Evidence. Pinsky PF; Prorok PC; Kramer BS N Engl J Med; 2017 Mar; 376(13):1285-1289. PubMed ID: 28355509 [No Abstract] [Full Text] [Related]
8. Missing the mark on prostate-specific antigen screening. Miller DC; Hollenbeck BK JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542 [No Abstract] [Full Text] [Related]
9. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P; Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643 [TBL] [Abstract][Full Text] [Related]
11. States renewing attention to prostate cancer. Rossiter C NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022 [No Abstract] [Full Text] [Related]
12. The Roles of Providers and Patients in the Overuse of Prostate-Specific Antigen Screening in the United States. Guo F; He D Ann Intern Med; 2015 Oct; 163(8):650-1. PubMed ID: 26502132 [No Abstract] [Full Text] [Related]
13. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer. Kwiatkowski M; Klotz L; Hugosson J; Recker F Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762 [No Abstract] [Full Text] [Related]
14. Grading the new US Preventive Services Task Force prostate cancer screening recommendation. Volk RJ; Wolf AM JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540 [No Abstract] [Full Text] [Related]
15. [Analysis of recommendations against prostate cancer screening with prostate specific antigen]. Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747 [No Abstract] [Full Text] [Related]
16. Prostate cancer screening--time to abandon one-size-fits-all approach? Kim J; Davis JW JAMA; 2011 Dec; 306(24):2717-8. PubMed ID: 22203541 [No Abstract] [Full Text] [Related]
17. The pendulum swings back: Screening for prostate cancer in 2018. Thompson IM Cancer; 2018 Jul; 124(13):2690-2692. PubMed ID: 29786846 [No Abstract] [Full Text] [Related]
18. Prostate Cancer Screening. Dunn MW Semin Oncol Nurs; 2017 May; 33(2):156-164. PubMed ID: 28343840 [TBL] [Abstract][Full Text] [Related]
19. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand. Mathew P; Hachem H; Han P JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576 [No Abstract] [Full Text] [Related]
20. Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer. Pini G; Collins J; Ghadjar P; Wiklund P Curr Urol Rep; 2015 May; 16(5):28. PubMed ID: 25773347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]